Bone Tuberculous Granulomatous Inflammation Mimicking Malignancy on 68Ga-FAPI PET/CT

被引:17
作者
Gong, Weidong [1 ,2 ,3 ]
Yang, Xiao [1 ,2 ,3 ]
Mou, Chunru [3 ,4 ]
Liu, Huipan [1 ,2 ,3 ]
Zhang, Chunyin [1 ,2 ,3 ]
机构
[1] South West Med Univ, Dept Nucl Med, Affiliated Hosp, Luzhou 646000, Sichuan, Peoples R China
[2] Nucl Med & Mol Imaging Key Lab Sichuan Prov, Luzhou, Sichuan, Peoples R China
[3] Acad Expert Workstat Sichuan Prov, Luzhou, Sichuan, Peoples R China
[4] Southwest Med Univ, Affiliated Hosp, Dept Pathol, Luzhou, Sichuan, Peoples R China
关键词
extrapulmonary tuberculosis; tuberculous granuloma; bone destruction; Ga-68-FAPI PET/CT; CANCER;
D O I
10.1097/RLU.0000000000003990
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A 50-year-old woman presented with back pain for 1 month. Chest CT showed osteolytic destruction of T6 vertebral body. A malignancy was suspected. The patient was subsequently enrolled in the clinical trial of 68Ga-FAPI PET/CT. 68Ga-FAPI PET/CT revealed multiple bone destruction with increased FAPI activity. It was also highly suggestive of malignancy or metastases. However, pathological examination after T6 vertebral surgery confirmed the diagnosis of tuberculous granulomatous inflammation. © Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:348 / 349
页数:2
相关论文
共 9 条
[1]   Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer [J].
Chen, Haojun ;
Pang, Yizhen ;
Wu, Jingxun ;
Zhao, Liang ;
Hao, Bing ;
Wu, Jing ;
Wei, Jihong ;
Wu, Siming ;
Zhao, Long ;
Luo, Zuoming ;
Lin, Xuehua ;
Xie, Chengrong ;
Sun, Long ;
Lin, Qin ;
Wu, Hua .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (08) :1820-1832
[2]   68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers [J].
Giesel, Frederik L. ;
Kratochwil, Clemens ;
Lindner, Thomas ;
Marschalek, Manfred M. ;
Loktev, Anastasia ;
Lehnert, Wencke ;
Debus, Juergen ;
Jaeger, Dirk ;
Flechsig, Paul ;
Altmann, Annette ;
Mier, Walter ;
Haberkorn, Uwe .
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (03) :386-392
[3]   68Ga-FAPI and 18F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor [J].
Gu, Bingxin ;
Luo, Zhiguo ;
He, Xinhong ;
Wang, Jian ;
Song, Shaoli .
CLINICAL NUCLEAR MEDICINE, 2020, 45 (11) :865-867
[4]   Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy [J].
Hamson, Elizabeth J. ;
Keane, Fiona M. ;
Tholen, Stefan ;
Schilling, Oliver ;
Gorrell, Mark D. .
PROTEOMICS CLINICAL APPLICATIONS, 2014, 8 (5-6) :454-463
[5]   68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer [J].
Kratochwil, Clemens ;
Flechsig, Paul ;
Lindner, Thomas ;
Abderrahim, Labidi ;
Altmann, Annette ;
Mier, Walter ;
Adeberg, Sebastian ;
Rathke, Hendrik ;
Roehrich, Manuel ;
Winter, Hauke ;
Plinkert, Peter K. ;
Marme, Frederik ;
Lang, Matthias ;
Kauczor, Hans-Ulrich ;
Jaeger, Dirk ;
Debus, Juergen ;
Haberkorn, Uwe ;
Giesel, Frederik L. .
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (06) :801-805
[6]   Elevated 68Ga-FAPI Activity in Splenic Hemangioma and Pneumonia [J].
Liu, Huipan ;
Wang, Yingwei ;
Zhang, Wei ;
Cai, Liang ;
Chen, Yue .
CLINICAL NUCLEAR MEDICINE, 2021, 46 (08) :694-696
[7]   Increased 68Ga-FAPI Uptake in Chronic Cholecystitis and Degenerative Osteophyte [J].
Liu, Huipan ;
Chen, Zan ;
Yang, Xiao ;
Fu, Wenhui ;
Chen, Yue .
CLINICAL NUCLEAR MEDICINE, 2021, 46 (07) :601-602
[8]   Intense FAPI Uptake in Inflammation May Mask the Tumor Activity of Pancreatic Cancer in 68Ga-FAPI PET/CT [J].
Luo, Yaping ;
Pan, Qingqing ;
Zhang, Wen ;
Li, Fang .
CLINICAL NUCLEAR MEDICINE, 2020, 45 (04) :310-311
[9]   Value of [68Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis [J].
Zhou, Yue ;
Yang, Xin ;
Liu, Huipan ;
Luo, Wenbin ;
Liu, Hanxiang ;
Lv, Taiyong ;
Wang, Junzheng ;
Qin, Jianhua ;
Ou, Santao ;
Chen, Yue .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (11) :3493-3501